Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

2yrs ago Private Equity techcrunch Views: 245

Frumtak Ventures, one of the few VCs in Iceland, has raised its third fund, Frumtak III. The $57 million (ISK 7b, €48m) fund will focus on post-seed and Series A startups. The firm says its typical ticket size will range from $1-5 million (€850k-4.2m).

Frumtak was a somewhat lesser-known European VC until it popped up on our radar as the backers behind the Controlant real-time supply chain monitoring startup, the technology from which was pictured beside Andrew Cuomo, governor of New York, when he held up a box containing the first-ever shipment of the COVID-19 vaccine to the city. Controlant has been a key player in the global distribution cold chain associated with vaccines.

However, the fund has also backed digital banking solutions provider Meniga, digital therapeutics scaleup Sidekick Health, travel CRM and travel booking system provider Kaptio, live event and fan engagement data analytics company Activity Stream, and Data Market, which was acquired by Qlik in 2014.

Svana Gunnarsdottir, managing partner of Frumtak Ventures said: “We are proud of the accomplishments of our portfolio companies and their teams, as well as the investment decisions we made through our first two funds. We look forward to continuing our support of high-potential startups and brilliant founders with Frumtak III. We are also grateful for the confidence shown to us by our LPs, many of whom have been with us since our first fund in 2009.”

Concurrently, Asthildur Otharsdottir has joined the firm as partner and Frumtak III’s lead investment manager. Otharsdottir was previously Frumtak’s Chairman for six years and has been on the board of Marel and Icelandair Group.


Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.